Investment Analysts’ updated eps estimates for Monday, November 13th:

Barratt Developments PLC Unsponsored ADR (OTCMKTS:BTDPY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Barratt Developments plc engages in the business of developing residential and non residential properties primarily in the United Kingdom. The company develops houses in towns, cities and rural areas. It operates under brands for house building- Barratt Homes and David Wilson Homes. The company’s commercial property development business, Wilson Bowden Developments is focused on retail, leisure, office, industrial and mixed-use schemes. Barratt Developments plc is headquartered in London, the United Kingdom. “

Calix (NYSE:CALX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Calix is a global leader in access innovation. Its Unified Access portfolio of broadband communications access systems and software enables communications service providers worldwide to transform their networks and become the broadband provider of choice to their subscribers. “

Cars.com (NASDAQ:CARS) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Cars.com Inc. operates an online automotive platform. The Company offers new and used vehicle listings, expert and consumer reviews, research tools and other information. It also engaged in the sale of display advertising to national advertisers. Cars.com Inc. is based in Chicago, United States. “

Cascadian Therapeutics (NASDAQ:CASC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $4.50 price target on the stock. According to Zacks, “Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company’s product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian Therapeutics, Inc., formerly known as Oncothyreon Inc., is headquartered in Seattle, Washington. “

Caseys General Stores (NASDAQ:CASY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Casey’s General Stores, Inc. operate convenience stores under the name Casey’s General Store in Midwestern states, primarily Iowa, Missouri and Illinois. The stores carry a broad selection of food (including freshly prepared foods such as pizza, donuts and sandwiches), beverages, tobacco products, health and beauty aids, automotive products and other non-food items. In addition, all stores offer gasoline for sale on a self-service basis. “

ChemoCentryx (NASDAQ:CCXI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California. “

TCG BDC (NASDAQ:CGBD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “TCG BDC, Inc. is an externally managed specialty finance company. It focused on providing flexible financing solutions to middle market companies primarily located in the United States. TCG BDC, Inc. is based in New York, United States. “

The Chefs’ Warehouse (NASDAQ:CHEF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Chefs’ Warehouse Holdings, LLC is a distributor of specialty food products in the United States. The Company is focused on serving the specific needs of chefs who own and/or operate restaurants, fine dining establishments, country clubs, hotels, caterers, culinary schools and specialty food stores. Its product portfolio includes artisan charcuterie, specialty cheeses, unique oils and vinegars, hormone-free protein, truffles, caviar, and chocolate. It also offers cooking oils, butter, eggs, milk, and flour. Chefs’ Warehouse Holdings, LLC is based in Ridgefield, Connecticut. “

Capitol Acquisition Corp. III (NYSE:CISN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $13.00 price target on the stock. According to Zacks, “Cision Ltd. operates as a software company. Its product portfolio consists of PR Software, Social Software, Government Relations and PAC Software, PRWeb and Help a reporter out. The company serves industries which include Pharmaceuticals and Bio-Tech, Banking, Technology, Travel and Hospitality. Cision Ltd, formerly known as Capitol Acquisition Corp. III, is based in Chicago, United States of America. “

Cloud Peak Energy (NYSE:CLD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cloud Peak Energy operates as a producer of low sulfur, high quality, sub-bituminous coal in the United States. It owns and operates three surface coal mines in the Powder River Basin named: Antelope, Cordero Rojo and the Spring Creek Mine. The Antelope Mine and Cordero Rojo Mine are located in Wyoming and the Spring Creek Mine is located near Decker, Montana. The company is headquartered in Gillette, Wyoming. “

Chimerix (NASDAQ:CMRX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina. “

Carpetright plc (LON:CPR) had its neutral rating reiterated by analysts at Goldman Sachs Group, Inc. (The).

Corindus Vascular Robotics (NYSEMKT:CVRS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.00 price target on the stock. According to Zacks, “Corindus Vascular Robotics, Inc. is involved in designing, manufacturing and selling precision vascular robotic-assisted systems for interventional vascular procedures. The Company’s product includes CorPath 200 system a vascular robotic system which provide stent placement in percutaneous coronary intervention procedures. Corindus Vascular Robotics, Inc. is based in Waltham, Massachusetts. “

DCP Midstream Partners, (NYSE:DCP) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “DCP Midstream Partners, LP is a midstream master limited partnership that gathers, treats, compresses, processes, transports and markets natural gas and transports and markets natural gas liquids. DCP Midstream Partners, LP is managed by its general partner, DCP Midstream GP, LLC, which is wholly owned by Duke Energy Field Services, a joint venture between Duke Energy and ConocoPhillips. It is a midstream master limited partnership formed by Duke Energy Field Services to own, operate, acquire and develop a diversified portfolio of complementary midstream assets. Supported by its relationship with Duke Energy Field Services and its parents, Duke Energy and ConocoPhillips, it intend to acquire and construct additional assets and have a management team dedicated to executing our growth strategies. “

Receive News & Ratings for Barratt Developments PLC Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barratt Developments PLC Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.